Results 71 to 80 of about 30,872 (257)
Saudi Journal of Oral Sciences, 2019 Background: Change in the distribution profile of nonalbicans Candida species (spp.) can be an indication of immunosuppression or drug resistance to oral candidiasis in patients with human immunodeficiency virus (HIV).
Varun Nair, Arvind Shetti
doaj +1 more source
Empirical Analysis of Oral and Nasal Vowels of Konkani [PDF]
arXiv, 2023 Konkani is a highly nasalised language which makes it unique among Indo-Aryan languages. This work investigates the acoustic-phonetic properties of Konkani oral and nasal vowels. For this study, speech samples from six speakers (3 male and 3 female) were collected.
arxiv
Neonatal thrush of newborns: Oral candidiasis? [PDF]
Clinical and Experimental Dental Research, 2019 AbstractObjectivesNeonatal thrush, also called oral candidiasis, is commonly a clinical diagnosis based on white patches on oral mucosal surfaces. Candida albicans is often associated with it. This clinical study aimed to investigate the presence of C. albicans among newborns with or without clinical findings of candidiasis on oral mucosa.
Jenni Tuomi +4 more
openaire +4 more sources
Smart Molecules, EarlyView.A mitochondria‐targeted AIE photosensitizer, LIQ‐TPA‐TZ, was developed to fight against Candida infection. It can efficiently produce reactive oxygen species to kill Candida guilliermondii and eradicate biofilms. It not only disrupted the respiratory chain and affected the metabolism and energy supply but also reduced the fungi adhesion and filament ...
Kun‐Mei Liu +5 more
wiley +1 more source
Journal of Oral Microbiology, 2021 Introduction Bacterial and fungal secondary infections following COVID-19 disease are widely being reported and are an area that should receive careful attention.
Manjusha Nambiar +5 more
doaj +1 more source
The Journal of Dermatology, EarlyView.Abstract Secukinumab is one of the human monoclonal antibodies recommended in the Japanese guidelines for patients with psoriasis, but few case reports and clinical studies on secukinumab for pustular psoriasis are available because of the rarity of the disease.
Ayako Fujishige, Noriko Seko
wiley +1 more source
The Journal of Dermatology, EarlyView.Abstract We report findings from a post‐marketing study conducted from November 2016 to September 2022, which evaluated the safety and effectiveness of ixekizumab in Japanese patients with psoriasis under routine clinical practice for up to 52 weeks, and the incidence of serious infections and malignancies for up to 3 years.
Hideshi Torii +8 more
wiley +1 more source
Gaining More Insight into the Determinants of Species Pathogenicity in the Oral Cavity
European Journal of Inflammation, 2014 Candida infection (candidiasis) is potentially life threatening and can occur in almost all anatomical sites, including the mouth. Candida species are in fact the most common fungal pathogens isolated from the oral cavity and frequently cause superficial
M.H. Arzmi +6 more
doaj +1 more source
Oral candidiasis in patients with renal transplants
Medicina Oral Patología Oral y Cirugia Bucal, 2013 Oral candidiasis (OC) is a frequent oral lesion in renal transplant patients (RTPs). Despite the increased prevalence of OC in RTPs, no study has examined related risk factors. The aims of this study were to analyze the prevalence of and risk factors for OC in RTPs compared with age- and gender-matched healthy control group (HC) as well as determine ...
López Pintor, Rosa María +3 more
openaire +4 more sources
The Journal of Dermatology, EarlyView.Abstract Guselkumab is a monoclonal antibody that binds to the p19 subunit of interleukin‐23 and inhibits its downstream signaling. The safety profile of guselkumab and its superior efficacy over placebo and adalimumab for the treatment of patients with moderate‐to‐severe psoriasis were reported in phase 3 studies conducted within and outside Japan. To
Yayoi Tada +6 more
wiley +1 more source